Zurück zu Projekte

12638.1;12 PFLS-LS

TOWARDS A NOVEL COMBINATION THERAPY AGAINST HUMAN TUMORS BASED ON THE SYNERGISTIC ANTI-CANCER EFFECT OF TWO NON-CANCER DRUGS

Zusammenfassung

TOWARDS A NOVEL COMBINATION THERAPY AGAINST HUMAN TUMORS BASED ON THE SYNERGISTIC ANTI-CANCER EFFECT OF TWO NON-CANCER DRUGS

Weitere Texte

Abstract

It was recently discovered at the University of Basel that combining a well known metabolic drug with a drug not previously reported to have any potential for the treatment of cancer led to an unexpected and synergistic anti-tumor effect. We aim to pursue this novel anti-cancer approach to the clinic. Proposed are chemical modifications to optimize one of the combination partners, as well as toxicological and pharmacological studies. In parallel, mechanistic studies, including identification of drug binding/effector genes, will be performed in order to define biomarkers of drug response and guide drug development.

Beteiligte

Michael Hall

Kontaktperson

m.hall@unibas.ch

Universität Basel Michael Hall Klingelbergstrasse 70 4056 Basel BS CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2011-09-30
Enddatum
2014-06-16
Bewilligte Gesamtkosten
CHF 681440.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Nicht aufteilbare / nicht zuteilbare Forschung

Forschungsdisziplinen

  • T490 Biotechnology 100.0%